Ironwood Pharmaceuticals is trading at $4.02 (6.1%) up after-hours, rebounding from a recent multi-day slide despite a lack of fresh company-specific headlines or earnings releases.
- The move appears to be a liquidity-driven bounce occurring in thinner after-hours trading, which can often amplify price swings.
- The recovery comes amid a volatile broader market session that saw major indices finish sharply lower.
- No new fundamental developments or regulatory filings have been identified to account for the sudden price action.